Lotus Pharm vs We Can Medicines: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and We Can Medicines (6929) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ We Can Medicines

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYWe Can MedicinesYoY
Oct 2026NT$2.13 billion-22.5%NT$284 million+4.5%
Sep 2026NT$2.77 billion+128.0%NT$266.4 million+5.2%
Aug 2026NT$2.11 billion+81.7%NT$275.4 million+2.0%
Jul 2026NT$2.49 billion+3.9%NT$270 million+1.3%
Jun 2026NT$3.4 billion+225.5%NT$257.4 million-4.3%
May 2026NT$2.32 billion+105.8%NT$282.9 million-0.2%
Apr 2026NT$3.09 billion+19.9%NT$262.3 million-0.8%
Mar 2026NT$4.35 billion+173.6%NT$272 million+2.5%
Feb 2026NT$2.24 billion+131.5%NT$260 million+3.8%
Jan 2026NT$2.05 billion-5.5%NT$264.8 million-6.1%
Dec 2025NT$2.44 billion+66.9%NT$272.1 million-2.6%
Nov 2025NT$1.06 billion-0.2%NT$273.6 million+0.7%
Oct 2025NT$2.75 billion+46.0%NT$271.9 million+3.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16